University of Michigan, Department of Emergency Medicine, 1500 East Medical Center Drive, B1-380 Taubman Center, SPC 5305, Ann Arbor, MI, 48109, United States.
Kansas City University of Medicine and Biosciences, 1750 Independence Ave, Kansas City, MO, 64106, United States.
Resuscitation. 2017 Oct;119:56-62. doi: 10.1016/j.resuscitation.2017.08.003. Epub 2017 Aug 5.
Extracorporeal cardiopulmonary resuscitation (ECPR) is an emerging therapy for refractory cardiac arrest. The purpose of this study was to analyze and report characteristics and outcomes of adult patients treated with ECPR after out-of-hospital cardiac arrest (OHCA) in a large international registry.
The Extracorporeal Life Support Organization's Extracorporeal Life Support Registry was queried for adult cardiac arrests with arrest location of "EMT Transport" or "Outside Hospital."
From 2010-2016, 217 cases of ECPR following OHCA were reported in Europe (47%), Asia-Pacific (29%), and North America (24%). The median age was 52 years (IQR 45-62, range 18-87); 73% were male. The median duration of ECPR was 47h (IQR 17-94, range 0-711). Reported complications included hemorrhage (31.3%), limb complications (11.1%), circuit complications (8.8%), infection (7.4%), and seizures (5.5%). The rate of percutaneous coronary intervention (PCI) was higher in Europe (35.6%) and Asia-Pacific (25.8%) than North America (9.4%; p<0.01). Survival to hospital discharge was 27.6% (95% CI 22.1-34.0%), and male gender was independently associated with mortality (adjusted odds ratio 2.1 [95% CI 1.1-4.2], p<0.05). Survival did not differ by region, race, age, or year. Brain death was reported in 16.6% [95% CI 12.2-22.1%]; organ donation rate was not reported.
This international analysis of ECPR for refractory OHCA reveals a survival rate of 27.6%, demonstrates association of male gender with mortality, and highlights regional differences in PCI utilization. These results will help inform implementation and research of this potentially life-saving strategy for refractory OHCA.
体外心肺复苏(ECPR)是一种新兴的难治性心脏骤停治疗方法。本研究的目的是分析和报告在大型国际注册中心接受 ECPR 治疗的成年患者的特征和结局。
体外生命支持组织的体外生命支持登记处查询了在 EMT 转运或院外发生心脏骤停(OHCA)的成年心脏骤停病例。
2010 年至 2016 年,在欧洲(47%)、亚太地区(29%)和北美(24%)报告了 217 例 OHCA 后 ECPR。中位年龄为 52 岁(四分位距 45-62,范围 18-87);73%为男性。ECPR 的中位时间为 47 小时(四分位距 17-94,范围 0-711)。报告的并发症包括出血(31.3%)、肢体并发症(11.1%)、回路并发症(8.8%)、感染(7.4%)和癫痫发作(5.5%)。欧洲(35.6%)和亚太地区(25.8%)行经皮冠状动脉介入治疗(PCI)的比例高于北美(9.4%;p<0.01)。出院时存活率为 27.6%(95%CI 22.1-34.0%),男性与死亡率独立相关(校正比值比 2.1 [95%CI 1.1-4.2],p<0.05)。存活率不因区域、种族、年龄或年份而不同。报告脑死亡 16.6%[95%CI 12.2-22.1%];未报告器官捐赠率。
本研究对难治性 OHCA 的 ECPR 进行了国际分析,结果显示,27.6%的患者存活,男性与死亡率相关,并且突出了 PCI 使用的区域差异。这些结果将有助于为难治性 OHCA 实施和研究这种潜在的救命策略提供信息。